18f-alf-nota-octreotide
PeptideexperimentalImaging agent
Clinical trial activity
5 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
2
Phase 3
1
Phase 4
0
Earliest trial started Jan 2, 2018 (NCT03511768)
Timeline
Indications
Mechanism of action
- Somatostatin receptorRadiopharmaceutical
Somatostatin receptor radiopharmaceutical
Chemistry & pharmacology
- Multi-specific
- No
- Imaging
- 18-fluorine
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07104487 | Phase 2 | Mar 18, 2025 | Katholieke Universiteit Leuven |
| NCT05749289 | Phase 1 | Dec 20, 2022 | Chinese Academy of Medical Sciences |
| NCT04552847 | Phase 2/Phase 3 (Phase 3) | Oct 7, 2020 | Ghent University, Katholieke Universiteit Leuven, Nederlands Neonataal Netwerk (N3), the Netherlands, University of Antwerp |
| NCT03883776 | Phase 1 | Apr 11, 2019 | Katholieke Universiteit Leuven |
| NCT03511768 | Phase 1/Phase 2 (Phase 2) | Jan 2, 2018 | Central South University |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Katholieke Universiteit Leuven | Academic/Hospital | 3 | 3 | 3 | 2019 |
| Central South University | Academic/Hospital | 1 | 1 | 1 | 2018 |
| Chinese Academy of Medical Sciences | Academic/Hospital | 1 | 1 | 1 | 2022 |
| Ghent University | Academic/Hospital | 1 | 0 | 1 | 2020 |
| Nederlands Neonataal Netwerk (N3), the Netherlands | Academic/Hospital | 1 | 0 | 1 | 2020 |
| University of Antwerp | Academic/Hospital | 1 | 0 | 1 | 2020 |
6 organizations
Page 1 / 1